Caturkarda Depo Bangunan Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Caturkarda Depo Bangunan Tbk. trades at Rp246 (market cap 1.7T, 34.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 33.1K 24h volume). The key difference: Caturkarda Depo Bangunan Tbk. is far larger — about 10.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Caturkarda Depo Bangunan Tbk. is more actively traded (34.5K versus 33.1K). Which is the better fit depends on your goals.
| DEPO | OBAT | |
|---|---|---|
Market Cap | 1.7T | 167.37B |
Volume | 34.5K | 33.1K |
Lot | 345 | 331 |
Turnover | 8.51M | 8.17M |
Average Price | 246.65 | 246.91 |
Value | 8.51M | 8.17M |
Indicative Equilibrium Price | 250 | 246 |
Indicative Equilibrium Volume | 4K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Caturkarda Depo Bangunan Tbk (the “Company”) was established based on Notarial Deed No. 5 dated January 3, 1996 of Public Notary Mrs. Poerbaningsih Adi Warsito, S.H., a Notary in Jakarta. The Company commenced its commercial operations in 1996.
Read more on DEPO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →